Screening functional cardiac imaging remains a widely adapted approach to rule out pre-existing significant coronary artery disease [38] and has been effective in reducing the rate of myocardial infarction following IL-2 therapy; a similar strategy to identify those patients who are at risk of developing the most significant inflammatory LV dysfunction would be highly beneficial. Here, IL2 is linked to coronary artery disorder.